P/E ratio for ProPhase Labs (PRPH)
P/E ratio as of May 2024 (TTM): -19.7
According to ProPhase Labs's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -19.6667. At the end of 2022 the company had a P/E ratio of 8.09.
P/E ratio history for ProPhase Labs from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 8.09 | -52.6% |
| 2021 | 17.1 | -133.47% |
| 2020 | -51.0 | 624.87% |
| 2019 | -7.04 | -67.36% |
| 2018 | -21.6 | -2623.04% |
| 2017 | 0.8543 | -107.69% |
| 2016 | -11.1 | 62.96% |
| 2015 | -6.82 | 110.15% |
| 2014 | -3.24 | -106.05% |
| 2013 | 53.7 | -376.23% |
| 2012 | -19.4 | 204.1% |
| 2011 | -6.39 | 33.1% |
| 2010 | -4.80 | -24.08% |
| 2009 | -6.32 | -33.61% |
| 2008 | -9.52 | -60.07% |
| 2007 | -23.9 | -45.51% |
| 2006 | -43.8 | -191.85% |
| 2005 | 47.7 | -77.39% |
| 2004 | 211 | 18.84% |
| 2003 | 177 | -1905.58% |
| 2002 | -9.82 | -108.54% |
| 2001 | 115 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.